Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction

---

ENHOŞ A., KARAÇÖP E.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, cilt.17, ss.441-452, 2021 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 17
• Basım Tarihi: 2021
• Doi Numarası: 10.2147/tcrm.s307768
• Dergi Adı: THERAPEUTICS AND CLINICAL RISK MANAGEMENT
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals
• Sayfa Sayıları: ss.441-452
• Anahtar Kelimeler: acute myocardial infarction, aspirin, infarct size, primary prevention, PERCUTANEOUS CORONARY INTERVENTION, CARDIAC MAGNETIC-RESONANCE, LEFT-VENTRICULAR FUNCTION, PRIMARY PREVENTION, ADVERSE OUTCOMES, ELEVATION, TROPONIN, DISEASE, MORTALITY
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Background: The study aimed to evaluate the impact of antecedent aspirin use on infarct size, bleeding and composite endpoint in patients with de novo acute myocardial infarction.